Top questions about the exposome of PFAS revealed

Feb 11, 2021 | Blogs, Clinical, Environmental / Industrial, Life Science Research | 0 comments

According to the CDC, the exposome is “the measure of all the exposures of an individual in a lifetime and how those exposures relate to health.”

Read time: 6 minutes

During a recent webinar, Simon Roberts of SCIEX and Christian Lindh of Lund University shared their insights about chronic human exposure to per- and polyfluorinated alkyl substances (PFAS). They also answered many questions, which are compiled here in this blog with the hope that they will inspire your own exposome research.  

What is the typical route of entry into the human body for PFAS compounds, and what are the sources of PFAS?

Simon: The typical route of entry into the body is ingestion from water, food or dust. Because many PFAS are highly bioaccumulative, even very small amounts of PFAS in food or water can increase the body’s levels over time.

PFAS are diverse industrial chemicals used directly in final products and during the synthesis of other substances. The most prevalent PFAS are currently found in firefighting foam, known as aqueous film-forming foam (AFFF). AFFF-derived PFAS have contaminated the groundwater at thousands of sites worldwide where fire-suppression and fire-suppression tests using AFFF have been conducted. In addition, many plastics, especially fluoropolymers and some polyethylene and other non-fluorinated polymers, are synthesized using PFAS, which may then end up in final products such as food packaging, medical equipment and other plastics relevant to human exposure.

What is the toxic concentration of PFAS in humans, and can it be excreted from the body? If not, why do PFAS molecules accumulate in the body?

Simon: While the exact toxic concentration of PFAS is currently unknown , chronic exposure at commonly detected levels of PFAS in the human body, such as 1–5 ppb, could result in chronic toxicity to the human endocrine system.

PFAS molecules accumulate in humans via a protein-binding mechanism and are slowly excreted from the body. Studies indicate that urine is an important pathway for the excretion of PFAS. However, there can be significant interindividual variations in the excretion of PFAS in urine. Animals are different from humans, for example, and the type of PFAS can also be a factor. In humans, gender and likely genetics matter as well.

What solvent did you use to isolate PFAS from the blood sample?

Christian: PFAS is associated with proteins that are not covalently bound. By adding acetonitrile and/or methanol, you “crash” out proteins in the blood samples. You need to do a strong shaking for 30 minutes or put the samples in an ultrasonic bath.

Has any correlation study been performed between PFAS in plasma/blood and PFAS in urine? Does PFAS get excreted in the urine at all?

Christian: Yes, it is excreted in urine, with interindividual variations. We will soon submit an extensive study on this topic. In the meantime, if you’re interested, you can check out some examples in the following publications:

Xu, Y.; Fletcher, T.; Pineda, D.; Lindh, C.H.; Nilsson, C.; Glynn, A.; Vogs, C.; Norström, K.; Lilja, K.; Jakobsson, K.; Li, Y. Serum Half-Lives for Short- and Long-Chain Perfluoroalkyl Acids after Ceasing Exposure from Drinking Water Contaminated by Firefighting Foam. Environ Health Perspect. 2020 Jul, 128 (7), 77004. DOI: 10.1289/EHP6785 

Calafat, A.M.; Kato, K.; Hubbard, K.; Jia, T.; Botelho, J.C.; Wong, L.Y. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey. Environ Int. 2019 Oct, 131, 105048. DOI: 10.1016/j.envint.2019.105048 

Many thanks to Simon and Christian for their dedication to this subject matter and for answering these questions. To access the on-demand webinar, click here. Feel free to ask any additional questions in the comments below.

RUO-MKT-18-12706

About the Presenters

Simon Roberts (Senior Application Scientist, SCIEX)

Simon specializes in developing methods for PFAS analysis at SCIEX for both targeted and non-targeted analysis. Before working at SCIEX, Simon performed PFAS discovery research at Colorado School of Mines during his postdoctoral fellowship. He worked on projects that identified dozens of novel PFAS in groundwater and industrial chemicals. Recently, Simon has focused on educating the public about PFAS via his YouTube channel, Environmental Chemistry Explained.

 

 

 

Christian Lindh (Senior Lecturer, Occupational and Environmental Medicine, Lund University)

Christian has extensive experience in the method development of various biological and environmental monitoring techniques using mainly mass spectrometry as an analytical tool. He studies human exposure to toxicants in the general environment and in occupational settings and evaluates their impact on the human body, with a particular focus on epidemiological studies using small volumes of biobank samples. Christian has been involved in many studies about PFAS exposure over the past 10 years.


 

*This content does not constitute legal advice. You should consult counsel to assure your procedures comply with applicable law and that it meets your needs.

RUO-MKT-18-12706

Celebrating customer experience: Insights from SCIEX leaders

Customer Experience Day (CX Day) is a special occasion for SCIEX, celebrated every first Tuesday in October. It’s a day dedicated to recognizing the incredible value of our customers and the relentless dedication of our associates who strive to make every interaction meaningful. At SCIEX, our commitment to customer experience is woven into the fabric of everything we do. From providing cutting-edge solutions to offering unwavering support, we aim to build lasting relationships and exceed expectations. Join us as we delve into the insights from our leaders on what customer experience means to SCIEX and how it shapes our journey.

Why traditional MS/MS falls short for ADCs and how electron-activated dissociation (EAD) changes the equation

Antibody-drug conjugates (ADCs) are among the most promising—and analytically demanding—modalities in biopharma today. By combining large, heterogeneous antibodies with chemically labile payloads and linkers, ADCs introduce a level of structural complexity that challenges conventional analytical workflows. It also poses the challenge that the very features you need to measure are often the easiest to lose during analysis.

Six benefits of remote support every laboratory should know

Imagine having a tech expert at your fingertips to solve computer issues or a fitness trainer guiding you through workouts from the comfort of your home. In today’s fast-paced world, the ability to provide and receive service and support remotely is no longer a luxury but a necessity. Whether it’s troubleshooting a software issue, repairing a device, offering customer assistance, or enjoying the convenience of telehealth as a private individual, remote capabilities have revolutionized how businesses operate and how individuals get help

Posted by

Simon Roberts specializes in developing methods for PFAS analysis at SCIEX for both targeted and non-targeted analysis. Before working at SCIEX, Simon performed PFAS discovery research at Colorado School of Mines during his postdoctoral fellowship. He worked on projects that identified dozens of novel PFAS in groundwater and industrial chemicals. Recently, Simon has focused on educating the public about PFAS via his YouTube channel Environmental Chemistry Explained.

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network